Convection enhanced delivery of different molecular weight tracers of gadolinium-tagged polylysine

Journal of Neuroscience Methods

Volumn 219, Issue 1, 2013, Pages 169-175

  Hardy, Peter A ^a,b   Keeley, Dan ^c   Schorn, Greg ^d   Forman, Eric ^a   Ai, Yi ^a   Venugopalan, Ramakrishna ^d   Zhang, Zhiming ^a   Bradley, Luke H ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Advanced Technologies and Regenerative Medicine   (United States)

^d Codman and Shurtleff ^*  (United States)

Author keywords

Imaging tracers; Magnetic resonance imaging; Parkinson's disease; Volume of distribution

Indexed keywords

AGAROSE; GADOLINIUM; GADOLINIUM PENTETATE; POLYLYSINE; TRACER;

ARTICLE; CATHETER; GEL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; THERMODYNAMICS;

IMAGING TRACERS; MAGNETIC RESONANCE IMAGING; PARKINSON'S DISEASE; VOLUME OF DISTRIBUTION;

ALGORITHMS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CONTRAST MEDIA; CONVECTION; DRUG DELIVERY SYSTEMS; GADOLINIUM DTPA; IMAGE PROCESSING, COMPUTER-ASSISTED; INFUSIONS, INTRAVENOUS; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MOLECULAR WEIGHT; POLYLYSINE; PUTAMEN; SEPHAROSE;

EID: 84883004935     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2013.07.013     Document Type: Article

References (50)

1. Ai Y., Markesbery W., Zhang Z., Grondin R., Elseberry D., Gerhardt G.A., et al. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. The Journal of Comparative Neurology 2003, 461:250-261.
2. Astary G.W., Kantorovich S., Carney P.R., Mareci T.H., Sarntinoranont M. Regional convection-enhanced delivery of gadolinium-labeled albumin in the rat hippocampus in vivo. Journal of Neuroscience Methods 2010, 187:129-137.
3. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:2076-2080.
4. Bogdanov A.A., Weissleder R., Frank H.W., Bogdanova A.V., Nossif N., Schaffer B.K., et al. A new macromolecule as a contrast agent for MR-angiography - preparation, properties, and animal studies. Radiology 1993, 187:701-706.
5. Bruce N.J., Falavigna A., Johnson J.P., Hall J.S., Birch B.D., Yoon J.T., et al. Intracerebral clysis in a rat glioma model. Neurosurgery 2000, 46:683-691.
6. Caravan P. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Accounts of Chemical Research 2009, 42:851-862.
7. Chen M.Y., Lonser R.R., Morrison P.F., Governale L.S., Oldfield E.H. Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. Journal of Neurosurgery 1999, 90:315-320.
8. Chen Z-J., Gillies G.T., Broaddus W.C., Prabhu S.S., Fillmore H., Mitchell R.M., et al. A realistic brain tissue phantom for intraparenchymal infusion studies. Journal of Neurosurgery 2004, 101:314-322.
9. Drappatz J., Wen P.Y. Non-cytotoxic drugs as potential treatments for gliomas. Current Opinion in Neurology 2004, 17:663-673.
10. Fiandaca M.S., Forsayeth J.R., Dickinson P.J., Bankiewicz K.S. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 2008, 5:123-127.
11. Fields R. Measurement of amino groups in proteins and peptides. Biochemical Journal 1971, 124:581-590.
12. Gash D.M., Zhang Z., Ai Y., Grondin R., Coffey R., Gerhardt G.A. Trophic factor distribution predicts functional recovery in parkinsonian monkeys. Annals of Neurology 2005, 58:224-233.
13. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996, 380:252-255.
14. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nature Medicine 2003, 9:589-595.
15. Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., et al. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 2002, 125:2191-2201.
16. Groothuis D.R. The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro-Oncology 2000, 2:45-59.
17. Hamilton J.F., Morrison P.F., Chen M.Y., Harvey-White J., Pernaute R.S., Phillips H., et al. Heparin coinfusion during convection-enhanced delivery (CED) Increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Experimental Neurology 2001, 168:155-161.
18. He J., Liu G.Z., Gupta S., Zhang Y.M., Rusckowski M., Hnatowich D.J. Amplification targeting: a modified pretargeting approach with potential for signal amplification - proof of a concept. Journal of Nuclear Medicine 2004, 45:1087-1095.
19. Jagannathan J., Walbridge S., Butman J.A., Oldfield E.H., Lonser R.R. Effect of ependymal and pial surfaces on convection-enhanced delivery. Laboratory investigation. Journal of Neurosurgery 2008, 109:547-552.
20. Kim J.H., Astary G.W., Nobrega T.L., Kantorovich S., Carney P.R., Mareci T.H., et al. Dynamic contrast-enhanced MRI of Gd-albumin delivery to the rat hippocampus in vivo by convection-enhanced delivery. Journal of Neuroscience Methods 2012, 209:62-73.
21. Krauze M.T., Forsayeth J., Park J.W., Bankiewicz K.S. Real-time imaging and quantification of brain delivery of liposomes. Pharmaceutical Research 2006, 23:2493-2504.
22. Krauze M.T., Forsayeth J., Yin D.L., Bankiewicz K.S. Convection-enhanced delivery of liposomes to primate brain. Methods in Enzymology Liposomes, Pt G 2009, 349-362. N. Duzgunes (Ed.).
23. Krauze M.T., Vandenberg S.R., Yamashita Y., Ryuta S.A., Forsayeth J., Noble C., et al. Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Experimental Neurology 2008, 210:638-644.
24. Kunwar S., Prados M.D., Chang S.M., Berger M.S., Lang F.F., Piepmeier J.M., et al. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the cintredekin besudotox intraparenchymal study group. Journal of Clinical Oncology 2007, 25:837-844.
25. Lang A.E., Gill S., Patel N.K., Lozano A., Nutt J.G., Penn R., et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Annals of Neurology 2006, 59:459-466.
26. Lonser R.R., Walbridge S., Garmestani K., Butman J.A., Walters H.A., Vortmeyer A.O., et al. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. Journal of Neurosurgery 2002, 97:905-913.
27. Lopez K.A., Tannenbaum A.M., Assanah M.C., Linskey K., Yun J., Kangarlu A., et al. Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitors. Cancer Research 2011, 71:3963-3971.
28. Mamelak A.N., Jacoby D.B. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opinion on Drug Delivery 2007, 4:175-186.
29. Manfredsson F.P., Tumer N., Erdos B., Landa T., Broxson C.S., Sullivan L.F., et al. Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. Molecular Therapy 2009, 17:980-991.
30. Mardor Y., Rahav O., Zauberman Y., Lidar Z., Ocherashvilli A., Daniels D., et al. Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Research 2005, 65:6858-6863.
31. Morrison P.F., Lonser R.R., Oldfield E.H. Convective delivery of glial cell line-derived neurotrophic factor in the human putamen. Journal of Neurosurgery 2007, 107:74-83.
32. Murad G.J.A., Walbridge S., Morrison P.F., Garmestani K., Degen J.W., Brechbiel M.W., et al. Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to Pseudomonas exotoxin. Clinical Cancer Research 2006, 12:3145-3151.
33. Murad G.J.A., Walbridge S., Morrison P.F., Szerlip N., Butman J.A., Oldfield E.H., et al. Image-guided convection-enhanced delivery of gemcitabine to the brainstem. Journal of Neurosurgery 2007, 106:351-356.
34. Nguyen T.T., Pannu Y.S., Sung C., Dedrick R.L., Walbridge S., Brechbiel M.W., et al. Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. Journal of Neurosurgery 2003, 98:584-590.
35. Patel N.K., Bunnage M., Plaha P., Svendsen C.N., Heywood P., Gill S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Annals of Neurology 2005, 57:298-302.
36. Pippin C.G., Parker T.A., McMurry T.J., Brechbiel M.W. Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA monoclonal-antibody conjugates. Bioconjugate Chemistry 1992, 3:342-345.
37. Ruegg C.L., Andersonberg W.T., Brechbiel M.W., Mirzadeh S., Gansow O.A., Strand M. Improved in vivo stability and tumor targeting of bismuth-labeled antibody. Cancer Research 1990, 50:4221-4226.
38. Salvatore M.F., Ai Y., Fischer B., Zhang A.M., Grondin R.C., Zhang Z., et al. Point source concentration of GDNF may explain failure of phase II clinical trial. Experimental Neurology 2006, 202:497-505.
39. Sapra P., Shor B. Monoclonal antibody-based therapies in cancer: advances and challenges. Pharmacology Therapeutics 2013, 138:452-469.
40. Schneider G., Seidel R., Uder M., Wagner D., Weinmann H.J., Kramann B. In vivo microscopic evaluation of the microvascular behavior of FITC-labeled macromolecular MR contrast agents in the hamster skinfold chamber. Investigative Radiology 2000, 35:564-570.
41. Slevin J.T., Gash D.M., Smith C.D., Gerhardt G.A., Kryscio R., Chebrolu H., et al. Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal. Neurosurgical Focus 2006, 20:E1.
42. Spadaro A.C., Draghetta W., Nassifdellama S., Camargo A.C.M., Greene L.J. Convenient manual trinitrobenzenesulfonic acid method for monitoring amino-acids and peptides in chromatographic column effluents. Analytical Biochemistry 1979, 96:317-321.
43. Su X., Kells A.P., Huang E.J., Lee H.S., Hadaczek P., Beyer J., et al. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys. Human Gene Therapy 2009, 20:1627-1640.
44. Thorne R.G., Lakkaraju A., Rodriguez-Boulan E., Nicholson C. In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:8416-8421.
45. Vallera D.A., Elson M., Brechbiel M.W., Dusenbery K.E., Burns L.J., Jaszcz W.B., et al. Radiotherapy of CD19 expressing Daudi tumors in nude mice with yttrium-90-labeled anti-CD19 antibody. Cancer Biotherapy and Radiopharmaceuticals 2004, 19:11-23.
46. Van Hecke P., Marchal G., Bosmans H., Johannik K., Jiang Y., Vogler H., et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magnetic Resonance Imaging 1991, 9:313-321.
47. Vexler V.S., Clement O., Schmittwillich H., Brasch R.C. Effect of varying the molecular-weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns. Journal of Magnetic Resonance Imaging 1994, 4:381-388.
48. Vitaliano G.D., Vitaliano F., Rios J.D., Renshaw P.F., Teicher M.H. New clathrin-based nanoplatforms for magnetic resonance imaging. PLoS ONE 2012, 7:e35821.
49. Yang J.J., Yang J., Wei L., Zurkiya O., Yang W., Li S., et al. Rational design of protein-based MRI contrast agents. Journal of the American Chemical Society 2008, 130:9260-9267.
50. Zhang Z., Miyoshi Y., Lapchak P.A., Collins F., Hilt D., Lebel C., et al. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys. The Journal of Pharmacology and Experimental Therapeutics 1997, 282:1396-1401.